Sneezing, itching, nasal congestion? Commonly called Allergic Rhinitis these symptoms are commonly triggered by allergens such as pollen, pet dander, and dust mites, and affects a significant portion of the population. Traditionally, management of these allergies has focused on symptomatic relief through antihistamines, nasal corticosteroids, and lifestyle adjustments. Complete cures for allergies are uncommon, as most treatments do not address the underlying cause of the allergic response. They help in managing the symptoms.
Acarizax, also known as 12 SQ-HDM SLIT, is a revolutionary advance in the treatment of house dust mite (HDM) allergies. Developed by ALK-Abelló, this sublingual immunotherapy tablet has been recommended by the National Institute for Health and Care Excellence (NICE) for people aged 12 to 65 suffering from persistent moderate to severe HDM-induced allergic rhinitis that does not respond to traditional treatments.
Unlike conventional therapies that merely alleviate symptoms, Acarizax targets the actual cause by desensitizing the immune system to HDM allergens. Taken daily, the tablet dissolves under the tongue, delivering a consistent dose of HDM extract. Over a treatment course of three years, the medication aims to build the body’s tolerance to dust mites, thus reducing the severity of allergic reactions.
The introduction of Acarizax could benefit around 13,000 people in England who have struggled with debilitating symptoms such as sneezing, nasal congestion, and itchy, watery eyes. These symptoms often lead to considerable disruptions to daily life, including impaired sleep and reduced productivity at work or school. By addressing the underlying allergy, Acarizax offers the potential for long-term relief and improved quality of life.
Accurate diagnosis is crucial to determine eligibility for Acarizax therapy. Candidates must have a confirmed HDM allergy, established through a detailed clinical history and positive results from specific tests such as skin prick testing or measurement of specific immunoglobulin E (IgE) levels. This ensures that the treatment is appropriately targeted to those who will benefit most.
While many allergies have historically been managed rather than cured, Acarizax offers a potential treatment for those afflicted by moderate to severe HDM allergies. By focusing on desensitising the immune system, this therapy not only alleviates symptoms but also addresses the fundamental cause of the allergic response, marking a significant development in allergy treatment.
Dr Helen Evans-Howells, a Bournemouth GP and expert in allergy patients, said the evidence “clearly” showed the treatment was an “effective solution”.
For more information on specific IgE allergy testing click here.
More Information;
www.bbc.co.uk/news/articles/c5y6lq2yd9zo
At home health tests are everywhere – but do they really work? Since the introduction of COVID-19 testing at home the home testing market has exploded. But, are all the promises accurate? Are we left with more questions than answers? How legitimate are they?
Personalised medicine is a form of medicine that uses information about your genes, proteins, environment, and lifestyle to prevent, diagnose, or treat disease. Learn more about how you could benefit from these advances.
It’s nearly that time again! Mince pies and hot chocolate. But for lots of us these treats can cause anything from mild digestive problems to severe reactions. Learn more about the difference between food allergies, intolerances and coeliac disease.
In the UK about 10,000 people are diagnosed with bladder cancer each year. The main symptom is blood in the urine which involves an invasive hospital procedure to look inside the bladder. A new non-invasive test could be the answer.
Forensic Genomics Innovation Hub
Laboratory 12
Southampton Science Park
1 Venture Road
Southampton
SO16 7NP
United Kingdom
Email: lab@fgih.co.uk
Phone: (+44) 02380118980
